US doctor arrives in London to assess 11-month-old Charlie Gard

An American doctor specializing in treating rare genetic conditions has arrived in London to examine Charlie Gard, an 11-month-old boy suffering from a critical illness that has damaged his brain and rendered him unable to breathe without assistance.

Dr. Michio Hirano, chief of the division of Neuromuscular disorders and a professor of neurology at Columbia University in New York City, arrived at Great Ormond Street Hospital today to help assess Charlie and weigh in on the next, or final, chapter of the baby’s life.

A U.K. judge extended invitations to Hirano, as well as a doctor from the Bambino Gesu hospital in Rome who has not been named, after evidence on a new experimental treatment was presented by the New York-based doctor by video link last Thursday in court. The hospital said each doctor will be given an “honorary contract,” which provides access to all the baby’s medical records and the hospital facilities over the next days. They will be allowed to examine Charlie and speak with his doctors and parents.

Columbia University Medical Center via AP
Dr. Michio Hirano is pictured in an undated handout photo released by Columbia University Medical Center on July 17, 2017.

Charlie suffers from mitochondrial depletion syndrome, a rare genetic disease that causes progressively increasing muscle weakness that leads to organ failure and becomes life-threatening within a few years. Though he is less than a year old, the baby has been on life support for several months.

His situation has drawn international attention in part because of the conflict between his parents, Connie Yates and Chris Gard, and doctors at Great Ormond Street Hospital. The baby’s parents want him to receive an experimental treatment to extend his life, while doctors at the hospital believe that such an intervention will not ultimately help him and only prolong his pain and suffering. The hospital, which wants to Charlie off life support, has prevailed in several rounds of court…

Read the full article from the source…

Leave a Reply

Your email address will not be published. Required fields are marked *